Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
07/26/2012 | WO2012097477A1 Methods and nucleotides for assessing tumor metastasis or prognosis in vitro |
07/26/2012 | WO2012097474A1 Method and system for detecting the insertion sites of transgenic foreign fragments |
07/26/2012 | WO2012097451A1 Leukocyte activation and methods of use thereof |
07/26/2012 | WO2012077898A3 Metabolic diseases-related odorant receptor genes and use thereof |
07/26/2012 | WO2012075506A3 Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses |
07/26/2012 | WO2012074904A3 Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents |
07/26/2012 | WO2012074202A3 Method of screening material for improving dry skin using bleomycin hydrolase |
07/26/2012 | WO2012071469A3 Histone demethylase inhibitors and uses thereof for treatment o f cancer |
07/26/2012 | WO2012071344A3 Nucleotide-based probes and methods for the detection and quantification of macromolecules and other analytes |
07/26/2012 | WO2012069659A3 Multimarker panel |
07/26/2012 | WO2012057548A3 Automatic real-time pcr system for the various analysis of biological smaple |
07/26/2012 | WO2012057498A3 Cell collection device |
07/26/2012 | WO2012048113A3 Biomarkers of cancer |
07/26/2012 | WO2012047865A9 Electrically conductive polymer nanowires with incorporated viruses |
07/26/2012 | WO2012047325A3 N-end rule protease activity indication methods and uses thereof |
07/26/2012 | WO2012031752A3 Tuberculosis mutants |
07/26/2012 | WO2012030196A9 Oligonucleotide marker and method for identifying the same |
07/26/2012 | WO2012011085A3 Kit useful for detecting donkey meat present in meat |
07/26/2012 | WO2011132061A3 Methylation profiling of dna samples |
07/26/2012 | WO2010092266A9 Statistical genetic amplification for the preconception-free identification of microorganisms by sequencing without any cloning step |
07/26/2012 | US20120192315 Resistance genes and proteins active against fusarium root rots, cyst nematodes and soybean sudden death syndrome and methods employing same |
07/26/2012 | US20120192305 Tomato line chi 18-2101 |
07/26/2012 | US20120192295 Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof |
07/26/2012 | US20120191009 Method and apparatus for in vivo surveillance of circulating biological components |
07/26/2012 | US20120190833 Method of selection, by two-dimensional separation, of nucleic acids that bind to a target with high affinity |
07/26/2012 | US20120190729 Mirna inhibition of six1 expression |
07/26/2012 | US20120190727 Method and means for treatment of osteoarthritis |
07/26/2012 | US20120190723 Viral modulators and processes thereof |
07/26/2012 | US20120190698 Methods of predicting thiopurine response |
07/26/2012 | US20120190676 Inhibitors of mtor kinase as anti-viral agents |
07/26/2012 | US20120190663 Use of free dna as an early predictor of severity in acute pancreatitis |
07/26/2012 | US20120190656 Methods for selecting therapies to improve hdl cholesterol and triglyceride levels |
07/26/2012 | US20120190630 Amino acid-based compounds, their methods of use, and methods of screening |
07/26/2012 | US20120190620 Methods to identify targets and molecules regulating purinosomes and their uses |
07/26/2012 | US20120190588 Methods for Identifying Agents that Inhibit Cell Migration, Promote Cell Adhesion and Prevent Metastasis |
07/26/2012 | US20120190587 Global Amplification Using A Randomly Primed Composite Primer |
07/26/2012 | US20120190585 Concurrent optimization in selection of primer and capture probe sets for nucleic acid analysis |
07/26/2012 | US20120190578 Plasma Complement Components as Expression Markers for Age-Related Macular Degeneration and Related Phenotypes |
07/26/2012 | US20120190577 Processes and methods for diagnosis of alzheimer's disease |
07/26/2012 | US20120190573 Biomarker of lung cancer |
07/26/2012 | US20120190572 Detecting genetic abnormalities |
07/26/2012 | US20120190568 Genetic markers associated with age-related macular degeneration, methods of detection and uses thereof |
07/26/2012 | US20120190565 Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm |
07/26/2012 | US20120190561 Means and methods for diagnosing endometriosis |
07/26/2012 | US20120190560 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
07/26/2012 | US20120190558 Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs |
07/26/2012 | US20120190557 Risk calculation for evaluation of fetal aneuploidy |
07/26/2012 | US20120190073 Process for large scale production of plasmid dna by e. coli fermentation |
07/26/2012 | US20120190061 Novel strategy to reduce lactic acid production and control ph in animal cell culture |
07/26/2012 | US20120190060 Microfluidic devices and methods for malaria detection |
07/26/2012 | US20120190059 Methods for obtaining hepatocytes, hepatic endoderm cells and hepatic progenitor cells by induced differentiation |
07/26/2012 | US20120190058 Method for evaluating cell populations |
07/26/2012 | US20120190054 Method of Analyzing Cellulose Decay in Cellulosic Material Hydrolysis |
07/26/2012 | US20120190053 Method of determining factor XIII with the aid of plasma-based reference material |
07/26/2012 | US20120190043 Enzymatic substrates for multiple detection systems |
07/26/2012 | US20120190039 Raf dimers and uses thereof |
07/26/2012 | US20120190038 LovD MUTANTS EXHIBITING IMPROVED PROPERTIES TOWARDS SIMVASTATIN SYNTHESIS |
07/26/2012 | US20120190037 Device and Method for Isolating Biological or Chemical Targets |
07/26/2012 | US20120190036 Clinical method for genotyping large genes for mutations that potentially cause disease |
07/26/2012 | US20120190035 Detection Of Disease Related Genes |
07/26/2012 | US20120190033 Droplet transport system for detection |
07/26/2012 | US20120190032 Droplet generation for droplet-based assays |
07/26/2012 | US20120190031 Marker for diagnosis of active multiple sclerosis |
07/26/2012 | US20120190029 Methods for detecting dna originating from different individuals |
07/26/2012 | US20120190028 Nucleic acids and methods for the detection of enterobacter sakazakii (cronobacter spp.) |
07/26/2012 | US20120190027 Ligation-based method of normalized quantification of nucleic acids |
07/26/2012 | US20120190026 Method of normalized quantification of rna |
07/26/2012 | US20120190024 Method for determining presence or absence of epithelial cancer-origin cell in biological sample, and molecular marker and kit therefor |
07/26/2012 | US20120190023 Methods for distinguishing between natural and artificial dna samples |
07/26/2012 | US20120190021 Detection of genetic abnormalities |
07/26/2012 | US20120190020 Detection of genetic abnormalities |
07/26/2012 | US20120190019 Concatameric ligation products: compositions methods and kits for same |
07/26/2012 | US20120190018 Enhanced risk probabilities using biomolecule estimations |
07/26/2012 | US20120190017 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications |
07/26/2012 | US20120190016 Compositions for use in identification of salmonella |
07/26/2012 | US20120190014 Phage phi 29 dna polymerase chimera |
07/26/2012 | US20120190013 Hydrolase enzyme substrates and uses thereof |
07/26/2012 | US20120190011 Compositions and methods for mammalian genetics and uses thereof |
07/26/2012 | US20120190010 Generic Matrix for Control Nucleic Acids |
07/26/2012 | US20120190009 Viral Modulators and Processes Thereof |
07/26/2012 | US20120190008 Generic pcr |
07/26/2012 | US20120190007 Method and system for monitoring and recording a viral infection process and that for screening vaccines |
07/26/2012 | US20120190006 Optoelectronic detection system |
07/26/2012 | US20120189711 Modular Extracorporeal Systems and Methods for Treating Blood-Borne Diseases |
07/26/2012 | US20120189663 Method of producing a medical composition |
07/26/2012 | US20120189662 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti |
07/26/2012 | US20120189659 Attenuated pestiviruses |
07/26/2012 | US20120189655 Attenuated Live Vaccine for Prevention of Porcine Reproductive and Respiratory Syndrome |
07/26/2012 | US20120189648 Infectious hepatitis c viruses of genotype 3a and 4a and uses thereof |
07/26/2012 | US20120189640 Methods and Compositions Related to Soluble Monoclonal Variable Lymphocyte Receptors of Defined Antigen Specificity |
07/26/2012 | US20120189625 Compositions and Methods for Treating Hematological Cancers Targeting the SIRPA CD47 Interaction |
07/26/2012 | US20120189613 Stim2-mediated capacitive calcium entry |
07/26/2012 | US20120189608 New endolysin obpgplys |
07/26/2012 | US20120189606 Antimicrobial Agents |
07/26/2012 | US20120186996 Determination of blood glucose in a small volume and in a short test time using short read potentials |
07/26/2012 | DE102008030907B4 Einrichtung und Verfahren zur Detektion und Verstärkung eines Signals Apparatus and method for the detection and amplification of a signal |
07/26/2012 | CA2827429A1 Polymerase preference index |
07/26/2012 | CA2825236A1 Leukocyte activation and methods of use thereof |
07/26/2012 | CA2825196A1 Systems and methods for sample use maximization |
07/26/2012 | CA2825094A1 Pvrl4 (nectin 4) is a receptor for measles virus |